A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17
Maurizio Chiriva‐Internati(Texas Tech University), Ronald C. Kennedy(Texas Tech University), Eldo E. Frezza(Texas Tech University), Fabio Grizzi(Humanitas University), W. Martin Kast(University of Southern California), Devin B. Lowe(Texas Tech University), Everardo Cobos(Texas Tech University), Yu Yuefei(Texas Tech University), Beatriz Velez(Texas Tech University), Raffaele Ferrari(Texas Tech University), Michael H. Shearer(Texas Tech University), Jon A. Weidanz(The University of Texas at Arlington)
Cited by 29
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549